These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29248267)

  • 1. A combined carrier-adjuvant system of peptide nanofibers and toll-like receptor agonists potentiates robust CD8+ T cell responses.
    Rudra JS; Banasik BN; Milligan GN
    Vaccine; 2018 Jan; 36(4):438-441. PubMed ID: 29248267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
    Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
    Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate Toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T cells.
    Schirmbeck R; Riedl P; Zurbriggen R; Akira S; Reimann J
    J Immunol; 2003 Nov; 171(10):5198-207. PubMed ID: 14607920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
    Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
    J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.
    Wille-Reece U; Wu CY; Flynn BJ; Kedl RM; Seder RA
    J Immunol; 2005 Jun; 174(12):7676-83. PubMed ID: 15944268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication.
    Maynard SK; Marshall JD; MacGill RS; Yu L; Cann JA; Cheng LI; McCarthy MP; Cayatte C; Robbins SH
    BMC Cancer; 2019 Jun; 19(1):540. PubMed ID: 31170937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic peptide nanofibers elicit adjuvant-free CD8⁺ T cell responses.
    Chesson CB; Huelsmann EJ; Lacek AT; Kohlhapp FJ; Webb MF; Nabatiyan A; Zloza A; Rudra JS
    Vaccine; 2014 Feb; 32(10):1174-80. PubMed ID: 24308959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis.
    Chesson CB; Huante M; Nusbaum RJ; Walker AG; Clover TM; Chinnaswamy J; Endsley JJ; Rudra JS
    Sci Rep; 2018 Aug; 8(1):12519. PubMed ID: 30131591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8
    Si Y; Wen Y; Kelly SH; Chong AS; Collier JH
    J Control Release; 2018 Jul; 282():120-130. PubMed ID: 29673645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates.
    Wille-Reece U; Flynn BJ; Loré K; Koup RA; Miles AP; Saul A; Kedl RM; Mattapallil JJ; Weiss WR; Roederer M; Seder RA
    J Exp Med; 2006 May; 203(5):1249-58. PubMed ID: 16636134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
    Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.
    Odegard JM; Flynn PA; Campbell DJ; Robbins SH; Dong L; Wang K; Ter Meulen J; Cohen JI; Koelle DM
    Vaccine; 2016 Jan; 34(1):101-9. PubMed ID: 26571309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells.
    Coelho-Dos-Reis JG; Huang J; Tsao T; Pereira FV; Funakoshi R; Nakajima H; Sugiyama H; Tsuji M
    Clin Immunol; 2016 Jul; 168():6-15. PubMed ID: 27132023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides.
    Zwaveling S; Ferreira Mota SC; Nouta J; Johnson M; Lipford GB; Offringa R; van der Burg SH; Melief CJ
    J Immunol; 2002 Jul; 169(1):350-8. PubMed ID: 12077264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8
    Xiang SD; Wilson KL; Goubier A; Heyerick A; Plebanski M
    Front Immunol; 2018; 9():2968. PubMed ID: 30631324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.
    Cheng WK; Wee K; Kollmann TR; Dutz JP
    Clin Vaccine Immunol; 2014 Mar; 21(3):329-39. PubMed ID: 24391136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
    Melssen MM; Petroni GR; Chianese-Bullock KA; Wages NA; Grosh WW; Varhegyi N; Smolkin ME; Smith KT; Galeassi NV; Deacon DH; Gaughan EM; Slingluff CL
    J Immunother Cancer; 2019 Jun; 7(1):163. PubMed ID: 31248461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge.
    Zhang X; Chentoufi AA; Dasgupta G; Nesburn AB; Wu M; Zhu X; Carpenter D; Wechsler SL; You S; BenMohamed L
    Mucosal Immunol; 2009 Mar; 2(2):129-143. PubMed ID: 19129756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.